VIRBAC CORP
8-K, 1999-03-17
PHARMACEUTICAL PREPARATIONS
Previous: FERRELLGAS PARTNERS L P, 10-Q, 1999-03-17
Next: VIRBAC CORP, 10-Q, 1999-03-17



                 SECURITIES AND EXCHANGE COMMISSION

                        Washington, D.C.  20549

                                 FORM 8-K



                              CURRENT REPORT


                     Pursuant to Section 13 or 15(d) of the
                       Securities and Exchange Act of 1934



        Date of Report (Date of earliest event reported):  March 5, 1999


                             Virbac Corporation
                   (formerly Agri-Nutrition Group Limited)
             (Exact name of registrant as specified in its charter)


  Delaware                          0-24312                      43-1648680
 (State of                  (Commission File No.)               (IRS Employer
Incorporation)                                               Identification No.)


                             3200 Meacham Boulevard
                            Fort Worth, Texas 76137
             (Address of principal executive offices, including zip code)



                                (817) 831-5030
              (Registrant's telephone number, including area code)




<PAGE>



ITEM 1.  CHANGES IN CONTROL OF REGISTRANT

     On March 5, 1999 (the "Effective Time"),  Virbac S.A., a French corporation
that manufactures veterinary  pharmaceuticals ("VBSA"),  acquired control of the
Company (as defined below) through its wholly owned subsidiary  Interlab S.A.S.,
a French  corporation  formed for the  purpose of holding  shares of the Company
("Interlab"),  in connection  with the merger (the "Merger") of Virbac,  Inc., a
Delaware corporation ("Virbac"), that manufactured and distributed animal health
products,  with and into Agri-Nutrition Group Limited  ("Agri-Nutrition"),  with
Agri-Nutrition  surviving the Merger and changing its name to Virbac Corporation
(the "Company").  Immediately after the Merger, all of Virbac's operating assets
were  transferred  to Virbac AH,  Inc., a Delaware  corporation  that is a newly
formed, wholly owned subsidiary of the Company that will continue the pre-Merger
business of Virbac.

     The  change  of  control  and the  Merger  were  effected  pursuant  to the
Agreement  and Plan of Merger,  dated  October 16, 1998, as amended (the "Merger
Agreement"),  among Agri-Nutrition,  VBSA, Virbac, and by addendum, Interlab. At
the Effective Time of the Merger,  the issued and  outstanding  shares of Virbac
Common Stock, then held by Interlab,  automatically  converted into the right to
receive  12,580,918  shares of the Company's Common Stock (the "Merger Shares"),
or  approximately  58% of the  Company's  outstanding  Common  Stock  after  the
Effective Time. Immediately prior to the Effective Time, VBSA, through Interlab,
made a cash  contribution  of  approximately  $15.7 million to Virbac (the "Cash
Infusion").  The Cash  Infusion  was made in order to (i) assure  that  Virbac's
outstanding  debt did not exceed its cash as recorded at December 31, 1998, (ii)
provide  for  approximately  $0.2  million of Virbac's  expenses  related to the
Merger,  (iii)  provide $3.0 million for a cash tender offer for up to 1 million
of the  Company's  shares at a price of $3.00 per share,  that is required to be
conducted  by the  Company  within  60 days  after the  Effective  Time and (iv)
provide approximately $3.7 million as working capital for the Company.

     In  addition,   the  Company  will,  in  March  2001,   and  under  certain
circumstances,  commence a second tender offer to purchase  1,395,000  shares of
the Company's  outstanding  Common Stock  (excluding  the Merger  Shares,  which
Interlab has agreed not to tender, and certain other shares) at a price of $3.00
per share.

         As of the  Effective  Date,  the Board of  Directors of the Company was
reconstituted  to  include  a  majority  of  directors  designated  by VBSA.  In
addition,  VBSA and  Agri-Nutrition  agreed  that,  as set  forth in the  Merger
Agreement,  Interlab  would  cause  its  directors  to  nominate  and vote for a
minority  stockholder  director  for election to a  successive  three-year  term
commencing at the annual meeting of stockholders in 2002.

ITEM 2.  ACQUISITION OR DISPOSITION OF ASSETS

         See Item 1.

ITEM 7.  FINANCIAL STATEMENTS AND EXHIBITS

         (a)  Financial statements of the business acquired.

         The following financial statements of Virbac are incorporated herein by
reference to the Proxy Statement of  Agri-Nutrition  for the 1999 Annual Meeting
of  Stockholders  filed with the Securities and Exchange  Commission on February
10, 1999 (file no. 0-24312):

                                                         2

<PAGE>



         Report of Independent Public Accountants
         Consolidated Balance Sheets as of December 31, 1997 and 1998
         Consolidated  Statement of Operations  for the Years Ended December 31,
             1996, 1997 and 1998 
         Consolidated  Statement of Stockholders' Equity for the Years Ended
             December 31, 1996, 1997, and 1998
         Consolidated Statement of Cash Flows for the Years Ended December 31, 
             1996, 1997 and 1998
         Notes to Consolidated Financial Statements

         (b) Pro Forma financial information.

         The following unaudited pro forma financial statements are incorporated
herein by reference to the Unaudited Pro Forma Financial  Information section of
the  Proxy  Statement  of   Agri-Nutrition   for  the  1999  Annual  Meeting  of
Stockholders  filed with the Securities and Exchange  Commission on February 10,
1999 (file no. 0-24312):

         Unaudited Pro Forma Condensed Combined Balance Sheet Data and the
             explanatory notes thereto
         Unaudited Pro Forma Combined Statement of Operations - 1998 and the 
             explanatory notes thereto

         (c)  Exhibits.

         2.1  Agreement  and Plan of Merger,  dated October 16, 1998, by and
              among  Agri-Nutrition,  VBSA,  Virbac and by addendum Interlab
              (incorporated  by  reference  to Exhibit 2.1 to Form 8-K filed
              with the Commission on November 17, 1998, file no. 0-24312)

         2.2  Addendum to the Agreement and Plan of Merger, dated January 
              18, 1999 (filed herewith)

         2.3  First Amendment to Agreement and Plan of Merger, dated November
              20, 1998 (filed herewith)

         2.4  Second Amendment to Agreement and Plan of Merger, dated 
              February 10, 1999 (filed herewith)

         99.1 Press release of the Company dated March 5, 1999 (filed herewith)

ITEM 8.  CHANGE IN FISCAL YEAR

         On March 5, 1999,  the Company  fiscal year end was changed to December
31.  Because the Company is accounting  for the Merger as a reverse  acquisition
and has adopted  the fiscal  year end of Virbac,  the  accounting  acquiror,  no
transition report will be filed.

         The next quarterly  report beyond the quarterly  report for the quarter
ended  January 31, 1999 will be filed for the  quarterly  period ended March 31,
1999 (based on the new fiscal year end).



                                                         3

<PAGE>


                                 SIGNATURE

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  registrant  has duly  caused  this report to be signed on its behalf by the
undersigned hereunto duly authorized.


                                      VIRBAC CORPORATION



                                      By:  /S/ ROBERT J. ELFANBAUM 
                                              Robert J. Elfanbaum
                                            Chief Financial Officer


Date: March 17, 1999

                                                         4



                                 INTERLAB S.A.S.

                          ADDENDUM TO MERGER AGREEMENT

        Pursuant to Section 6.11 of the Agreement  and Plan of Merger,  dated as
of October 16, 1998 (the "Merger Agreement"), among Agri-Nutrition Group Limited
("AGNU"),  Virbac S.A. ("VBSA") and Virbac, Inc. ("Virbac"),  Interlab S.A.S., a
French  corporation  and a wholly owned  subsidiary  of VBSA,  hereby  agrees to
become a party to the Merger  Agreement.  All  references  to  "Parent"  in this
Addendum and the Merger Agreement mean "Interlab S.A.S."

        Parent  hereby  represents  and  warrants  to AGNU that  Parent  has the
requisite  corporate power and authority to execute and deliver this Addendum to
Merger  Agreement (this  "Addendum"),  to become a party to the Merger Agreement
and  to  consummate  the  transactions  contemplated  hereby  and  thereby.  The
execution of this  Addendum and the  performance  of the  obligations  under the
Merger Agreement and of the other  transactions  contemplated  thereby have been
duly authorized by all necessary  corporate  action on the part of Parent and no
other  corporate  proceedings  on the part of Parent are  necessary to authorize
this Addendum or to consummate the  transactions  contemplated  under the Merger
Agreement.  This  Addendum has been duly  executed and  delivered by Parent and,
assuming the Merger  Agreement  constitutes  a valid and binding  obligation  of
AGNU, constitutes a valid and binding obligation of Parent,  enforceable against
Parent  in  accordance  with  the  terms of the  Merger  Agreement,  subject  to
applicable bankruptcy,  insolvency, moratorium or other similar laws relating to
creditors' rights generally and to general principles of equity.

        IN WITNESS  WHEREOF,  the parties hereto have caused this Addendum to be
executed and delivered as of the _____ day of __________________ 1998.


                                      AGRI-NUTRITION GROUP LIMITED

                                      By:                     
                                      Name:                    
                                      Title:                       


                                      VIRBAC S.A.

                                      By:                       
                                      Name:                    
                                      Title:                    








<PAGE>



                                           INTERLAB S.A.S.

                                           By:                   
                                           Name:                              
                                           Title:                 


                                           VIRBAC, INC.

                                           By:                 
                                           Name:                   
                                           Title:            








                               FIRST AMENDMENT TO
                          AGREEMENT AND PLAN OF MERGER

         THIS FIRST AMENDMENT TO AGREEMENT AND PLAN OF MERGER (this
"Amendment")  is made and entered into as of November  20, 1998,  by and between
Agri-Nutrition  Group limited, a Delaware corporation  ("AGNU"),  Virbac S.A., a
French  corporation   ("VBSA"),   and  Virbac,   Inc.,  a  Delaware  corporation
("Virbac").

         WHEREAS,  AGNU,  VBSA and Virbac have entered into a certain  Agreement
and Plan of  Merger,  dated as of October  16,  1998 (the  "Merger  Agreement"),
pursuant  to  which  Virbac  will  merge  with and into  AGNU  with  AGNU as the
surviving corporation.

         WHEREAS,  after  further  discussions,   AGNU,  VBSA  and  Virbac  have
determined to amend the Merger Agreement to reflect additional agreements of the
parties on issues affected by the Merger.

         NOW,  THEREFORE,  in  consideration  of the  foregoing  and the  mutual
covenants and agreements  contained  herein,  the parties hereto hereby agree as
follows:

1.       Defined Terms.  Capitalized  terms used in this Amendment will,  unless
         otherwise defined in this Amendment, have the meanings assigned to them
         in the Merger Agreement.

2.       Amendment of Article IV, Section 4.23 of the Merger Agreement.  Article
         IV, Section 4.23 of the Merger  Agreement is hereby amended by deleting
         the language thereof and substituting in lieu thereof the following:

                  "Section  4.23  Issuance of Shares.  The Merger Shares and the
         shares  issued  pursuant  to  the  Share   Adjustment  have  been  duly
         authorized  by  the  AGNU  Board  of  Directors  and,  when  issued  as
         contemplated by this Agreement,  will be validly issued, fully paid and
         nonassessable,  free of any  preemptive  rights  created by, and not in
         violation of, any statute,  the certificate of  incorporation  of AGNU,
         the  bylaws  of AGNU or any  agreement  to which  AGNU is a party or by
         which AGNU is bound.  The Merger Shares and the shares issued  pursuant
         to the Share  Adjustment  will be exempt  from  registration  under the
         Securities Act and under applicable Blue Sky Laws. The offering or sale
         of any of the Merger Shares and the shares issued pursuant to the Share
         Adjustment as  contemplated by this Agreement does not give rise to any
         rights,  other than those which have been waived or  satisfied,  for or
         relating to the registration of any securities of AGNU."

3.       Amendment  of Article  VI of the  Merger  Agreement.  (a)  Article  VI,
         Section 6.14 of the Merger  Agreement is hereby amended by deleting the
         references therein to "Section 7.3(d)" and substituting in lieu thereof
         references to "Section 7.1(e)."

                  (b)  Article VI,  Section  6.9(b) of the Merger  Agreement  is
         hereby amended by deleting the references  therein to "Section 10.1(h)"
         and substituting in lieu thereof references to "Section 10.1(g)."

4.       Amendment  of Article VII of the Merger  Agreement.  (a)  Article  VII,
         Section 7.2 of the Merger  Agreement is hereby  amended by adding a new
         paragraph "(g)" to Section 7.2 to read in its entirety as follows:


<PAGE>




                  "(g) Legal  Opinions  of VBSA's and  Virbac's  Counsel.  On or
         prior to the Closing  Date,  AGNU will have received the opinion of (i)
         McGregor  &  Adler,  LLP,  counsel  to  Virbac,   regarding  the  legal
         representations  contained  in Sections  3.1,  3.2, 3.3 and 3.4 of this
         Agreement and (ii) Herve Aoust,  legal  counsel to VBSA,  regarding the
         legal representations contained in Section 3.4, provided, however, that
         such  opinion  shall  substitute  VBSA in lieu of Virbac in such  legal
         representations."

                  (b) Article VII, Section 7.3 of the Merger Agreement is hereby
         amended by adding a new  paragraph  "(e)" to Section 7.3 to read in its
         entirety as follows:

                  "(e)  Legal  Opinion  of  AGNU's  Counsel.  On or prior to the
         Closing  Date,  VBSA and Virbac will have received the opinion of Dyer,
         Ellis & Joseph,  counsel to AGNU,  regarding the legal  representations
         contained in Sections 4.1, 4.2, 4.3, 4.4 and 4.23 of this Agreement."

5.       Amendment  of  Article  IX,  Section  9.1(a) of the  Merger  Agreement.
         Article IX, Section 9.1(a) of the Merger Agreement is hereby amended by
         deleting  the  phrase  "third  anniversary"  and  substituting  in lieu
         thereof the phrase "second anniversary."

6.       Amendment  of Article  X,  Section  10.1(i)  of the  Merger  Agreement.
         Article X, Section 10.1(i) of the Merger Agreement is hereby amended by
         deleting the language  thereof and  substituting  in lieu thereof a new
         Section 10.1(i) to read in its entirety as follows:

                  "(i) by (A) either  Virbac or AGNU on or before  November  20,
         1998 if such party objects to any of the matters  reviewed  pursuant to
         Section 6.1,  provided,  however,  that any objection  rendered by such
         party is based on reasonable and prudent business judgment and not made
         in an arbitrary  and  capricious  manner,  or (B) Virbac if it fails to
         receive an opinion of AGNU's environmental counsel in the form attached
         as Exhibit J hereto or assessment of an environmental  engineering firm
         acceptable to Virbac,  as the case may be;  provided  further,  that if
         Virbac is unable to complete  its  investigation  as a result of AGNU's
         failure to afford  reasonable  access to the  properties  and executive
         personnel  of  AGNU  or  promptly  provide  all  material   information
         requested by Virbac pursuant to Section 6.1, then Virbac may extend the
         termination date under this Section 10.1(i) to November 25, 1998; or".

7.       Amendment  of Exhibit C.  Exhibit C of the Merger  Agreement  is hereby
         amended by deleting the phrase "and, provided further, that Parent may"
         in Section 6 thereof.

8.       Amendment  of Exhibit I.  Exhibit I of the Merger  Agreement  is hereby
         amended by  deleting  the  language  of Exhibit I in its  entirety  and
         substituting in lieu thereof Exhibit I attached hereto.

9.       Amendment  of  Appendix  B.  Items  4.11 and 4.18 of  Appendix B to the
         Merger  Agreement  are hereby  amended by deleting the language of such
         items in their entirety and substituting in lieu thereof Items 4.11 and
         4.18 attached hereto.

10.      Reaffirmation  of Merger  Agreement.  To the extent that any  provision
         hereof  conflicts  with any  provision  of the  Merger  Agreement,  the
         provisions  hereof will control.  Except as expressly  modified hereby,
         the Merger  Agreement  remains  in full force and effect in  accordance
         with its original terms.

11.      Miscellaneous.


<PAGE>




         (a)  Counterparts.  This Amendment may be executed and delivered in one
or  more  counterparts,   and  by  the  different  parties  hereto  in  separate
counterparts, each of which when executed and delivered means be deemed to be an
original but all of which taken together constitute one and the same agreement.

         (b)  Governing  Law.  This  Amendment is governed by, and  construed in
accordance  with,  the laws of the State of Delaware  without  giving  effect to
applicable principles of conflicts of law.

         (c) Entire  Agreement.  This  Amendment,  the Merger  Agreement and the
Confidentiality  Agreement  (together  with the Exhibits,  the Schedules and the
other documents  delivered  pursuant to the Amendment and the Merger  Agreement)
constitute  the  entire  agreement  of the  parties  and  supersedes  all  prior
agreements and undertakings,  both written and oral, between the parties, or any
of them, with respect to the subject matter hereof.




<PAGE>



         IN WITNESS WHEREOF, the parties hereto have caused this First Amendment
to  Agreement  and Plan of Merger to be executed  and  delivered  as of the date
first written above.


AGRI-NUTRITION GROUP LIMITED




Bruce G. Baker
President and Chief Executive Officer


VIRBAC S.A.



By:                                                           
Name:                                                         
Title:                                                        

VIRBAC, INC.




Brian A. Crook
Chief Executive Officer





                               SECOND AMENDMENT TO
                          AGREEMENT AND PLAN OF MERGER


         THIS SECOND  AMENDMENT  TO AGREEMENT  AND PLAN OF MERGER (this  "Second
Amendment")  is made and  entered  into as of  February  10, 1999 by and between
Agri-Nutrition  Group Limited, a Delaware corporation  ("AGNU"),  Virbac S.A., a
French corporation  ("VBSA"),  Virbac, Inc., a Delaware corporation  ("Virbac"),
and Interlab S.A.S., a French corporation ("Parent").

         WHEREAS,  AGNU,  VBSA,  Virbac and Parent have  entered  into a certain
Agreement  and Plan of Merger,  dated as of October  16,  1998,  as amended by a
First  Amendment to Agreement and Plan of Merger,  dated as of November 20, 1998
(the "Merger Agreement"), pursuant to which Virbac will merge with and into AGNU
with AGNU as the surviving corporation.

         WHEREAS, after further discussions,  AGNU, VBSA, Virbac and Parent have
determined to amend the Merger Agreement to reflect additional agreements of the
parties on issues affected by the Merger.

         NOW,  THEREFORE,  in  consideration  of the  foregoing  and the  mutual
covenants and agreements  contained  herein,  the parties hereto hereby agree as
follows:

1.       Defined Terms.  Capitalized  terms used in this Second  Amendment will,
         unless otherwise  defined in this Second  Amendment,  have the meanings
         assigned to them in the Merger Agreement.

2.       Amendment  of Article  X,  Section  10.1(h)  of the  Merger  Agreement.
         Article X, Section 10.1(h) of the Merger Agreement is hereby amended by
         deleting  the  language  thereof and  substituting  in lieu thereof the
         following:

                  "(h) by  either  Virbac  or AGNU if the  Merger  has not  been
         consummated before March 15, 1999 (the "Termination  Date");  provided,
         however,  that (i) the right to  terminate  this  Agreement  under this
         Section 10.1(h) will not be available to Virbac if Parent's or Virbac's
         failure to use its commercially  reasonable best efforts to fulfill any
         obligation  under this Agreement has been the cause of, or resulted in,
         the failure of the Effective Time to occur on or before the Termination
         Date, and (ii) the right to terminate this Agreement under this Section
         10.1(h) is not available to AGNU if AGNU's  failure,  or the failure of
         its  stockholders who are subject to the  Stockholders'  Agreements set
         forth as Exhibit I hereto,  to use their  commercially  reasonable best
         efforts to fulfill any  obligation  under this  Agreement  has been the
         cause of, or resulted in, the failure of the Effective Time to occur on
         or before the Termination Date;".

3.       Miscellaneous.

         (a)  Counterparts.  This Second Amendment may be executed and delivered
in one or more  counterparts,  and by the different  parties  hereto in separate
counterparts, each of which when executed and delivered shall be deemed to be an
original but all of which taken together constitute one and the same agreement.

         (b) Governing Law. This Second  Amendment is governed by, and construed
in accordance  with, the laws of the State of Delaware  without giving effect to
applicable principles of conflicts of law.



<PAGE>


         (c) Entire Agreement.  This Second Amendment,  the Merger Agreement and
the Confidentiality Agreement (together with the Exhibits, the Schedules and the
other  documents  delivered  pursuant  to the  Second  Amendment  and the Merger
Agreement)  constitute  the entire  agreement of the parties and  supersedes all
prior agreements and undertakings,  both written and oral,  between the parties,
or any of them, with respect to the subject matter hereof.

         IN  WITNESS  WHEREOF,  the  parties  hereto  have  caused  this  Second
Amendment to Agreement and Plan of Merger to be executed and delivered as of the
date first written above.



                                         AGRI-NUTRITION GROUP LIMITED




                                         Bruce G. Baker
                                         President and Chief Executive Officer



                                         VIRBAC S.A.




                                         Michel Garaudet
                                         Director of Administration and Finance



                                         VIRBAC, INC.




                                         Brian A. Crook
                                         Chief Executive Officer


                                         INTERLAB S.A.S.




                                         Pascal Boissy
                                         President











Contact:          Robert J. Elfanbaum
                  Chief Financial Officer
                  (314) 298-7330
                                                         FOR IMMEDIATE RELEASE


                         AGRI-NUTRITION GROUP AND VIRBAC
                  COMPLETE MERGER, WILL INITIATE STOCK TENDER

MARYLAND HEIGHTS, Missouri (March 5, 1999) -- Agri-Nutrition Group Limited
(Nasdaq/NM:AGNU)  today  announced  the closing of its merger with Virbac,  Inc.
(Virbac),  the U.S.  subsidiary  of  Virbac  S.A.  (VBSA),  a French  veterinary
pharmaceutical  manufacturer,  forming a new company, Virbac Corporation,  which
will begin trading March 8, 1999, on the Nasdaq National Market under the symbol
VBAC. The merger was approved by  shareholders  of  Agri-Nutrition  Group at its
annual meeting on March 1, 1999.  Within the next two weeks, a public tender for
approximately 10% of the Company's  currently  outstanding Common Stock at $3.00
per share will be  initiated.  If the closing  price of the Common Stock has not
reached $3.00 for 40 consecutive trading days within two years after the merger,
the Company will  conduct a second  tender  offer for an  additional  15% of the
shares currently outstanding, also at $3.00 per share.

         Pascal Boissy,  president of VBSA,  will serve as chairman of the board
of the Fort Worth,  Texas-based  Virbac  Corporation;  Brian A.  Crook,  D.V.M.,
former chief executive officer of Virbac, will serve as chief executive officer;
Bruce G. Baker,  former president and chief executive  officer of Agri-Nutrition
Group Limited, will serve as executive vice president;  and Robert J. Elfanbaum,
chief financial officer of Agri-Nutrition Group, will continue to serve as chief
financial  officer.  Both Dr.  Crook and Mr.  Baker hold  seats on the  combined
company's  Board of  Directors  as do Mr.  Alec  Poitevint,  former  chairman of
Agri-Nutrition Group, and Dr. Pierre Pages, executive vice president of VBSA.

         Commenting  on the merger,  Dr. Crook  stated,  "We are pleased to have
completed this transaction which we believe will bring value to the shareholders
and customers of both companies.  The combined  management team will immediately
begin the  integration  of the two  companies  and will also  aggressively  seek
acquisition and alignment  candidates in support of our core business to deliver
continually improving value to those shareholders and customers."

         Mr. Baker added, "Now that the combination has been completed,  we look
forward  to  the  synergies   and  economies  of  scale  created   through  this
transaction.  As a company with sales of $50 million, Virbac Corporation has the
critical  mass,  financial  strength and skills  necessary to take  advantage of
opportunities in the rapidly consolidating companion animal industry."

         Virbac Corporation (Nasdaq/NM:VBAC), located in Fort Worth, Texas, is a
companion  animal health company  formed  through the merger of Virbac,  Inc., a
subsidiary of the $241 million  revenue  French  public  animal health  company,
Virbac,  S.A. (Second  Marche/SICOVAM:3157),  and Agri-Nutrition  Group Limited.
Virbac Corporation is a leader in health care products and services for pets and
companion  animals and serves its clients from operations in Fort Worth,  Texas;
St. Louis, Missouri; Los Angeles,  California; and Chicago, Illinois; as well as
a sales and distribution center in the United Kingdom.

                                                       -###-



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission